Clinical trials
Phase 2 Multiple Sclerosis trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 6 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2015 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Terminated | 6 |
| Recruiting | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 9 |
| Biogen | 3 |
| AbbVie | 2 |
| Actelion | 2 |
| GlaxoSmithKline | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Novartis Pharmaceuticals | 2 |
| Ottawa Hospital Research Institute | 2 |
| University of Calgary | 2 |
| AbbVie (prior sponsor, Abbott) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 44 |
| Multiple Sclerosis, Relapsing-Remitting | 7 |
| Multiple Sclerosis, Chronic Progressive | 5 |
| Demyelinating Diseases | 2 |
| Muscle Spasticity | 2 |
| Recurrence | 2 |
| Autoimmune Diseases | 1 |
| Autoimmune Diseases of the Nervous System | 1 |
| Diffuse Cerebral Sclerosis of Schilder | 1 |
| Disease Progression | 1 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.